IVOV Vanguard S&P Mid-Cap 400 Value ETF

Vanguard S&P Mid-Cap 400 Value ETF (IVOV) currently reports 305 stock positions (subject to change), placing it in the highly diversified range by holdings breadth. The top line-up is USFD (1.30%), RS (0.99%), AA (0.97%), with USFD as the largest single weight at 1.30%. Together, the top three holdings account for 3.26%, which implies a more democratized weight structure where the broader holding set matters as much as the leadership group. This structure gives the portfolio a dual character: meaningful exposure to its highest-conviction names, alongside enough breadth to dampen idiosyncratic noise.

Examining the portfolio through a capital allocation lens, ROIC is 8.24%, WACC is 7.82%, and the economic spread is 0.42%. On balance, holdings are generating returns above their cost of capital, though the margin is slim enough to warrant attention. Supporting metrics show ROE at 12.68% and ROA at 4.85%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Valuation currently screens at trailing P/E of 16.77, forward P/E of 13.32, PEG of 3.39. Trailing and forward P/E are close together, implying the market does not expect a significant change in the earnings trajectory over the near term. At this PEG level, the portfolio is priced generously relative to its expected earnings trajectory — execution risk is meaningfully priced in. The aggregate current ratio of 2.41 reflects a holding set with workable near-term liquidity positions. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.

From gross to free cash flow, gross margin sits at 40.66%, operating margin at 16.61%, and free cash flow margin at 14.25%. At this gross margin level, the holdings demonstrate adequate production efficiency without commanding premium pricing. The operating margin reading is healthy — adequate to support reinvestment without sacrificing profitability. The portfolio's FCF margin is modest — adequate for near-term needs but not indicative of exceptional capital efficiency. The margin profile warrants careful consideration — businesses with compressed margins have less room to absorb cost pressure or revenue softness.

Combining revenue momentum with analyst targets, the estimated 12-month price change of 18.38%, where consensus expectations favor gradual appreciation over the next year, while TTM revenue growth of 12.20% reflecting moderate but reliable revenue progress across the basket. Separating operating reality from market-implied expectations is useful here — they can diverge meaningfully when sentiment shifts. The forward return case hinges on whether the operating reality stays close enough to analyst assumptions for those targets to remain credible. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

The fundamental case holds up across most key dimensions — the combination of positive economic spread, reasonable valuation, and analyst support is constructive.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.